Researchers at the University of Southern Denmark have identified a previously unknown virus hiding inside a common gut ...

Prophage is being developed for the treatment of patients with newly diagnosed glioblastoma multiforme (GBM.V). Results from the study revealed that the median overall survival of approximately 24 ...

LEXINGTON, Mass., April 6, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) announced today that new data from a Phase 2 trial testing the Prophage G-200 vaccine (HSPPC-96; vitespen) in recurrent ...

A phage is a virus that invades a bacterial cell. While harmless to human cells, phages are potentially deadly to bacteria since many phages enter a cell in order to hijack its machinery in order to ...

It was confirmed the presence of Prophage and Jamphage in the Alkalihalobacillus clausii Prophage and Jamphage are expected to play a substantial role in bacterial survival and immune regulation in ...

Agenus Inc. AGEN announced that it has entered into a clinical trial collaboration with the National Cancer Institute (NCI) to evaluate its personalized autologous vaccine candidate, Prophage ...

In a recent study published in the journal PLoS Pathogens, researchers analyze prophages of the LF82 strain of adherent-invasive Escherichia coli (AIEC) to better understand their behavior in vitro ...

A phage is a virus that invades a bacterial cell. While harmless to human cells, phages are potentially deadly to bacteria since many phages enter a cell in order to hijack its machinery in order to ...

LEXINGTON, Mass., May 18, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) today announced that new data from a Phase 2 trial testing the Prophage G-200 vaccine (HSPPC-96; vitespen) in recurrent ...